TABLE OF CONTENTS
Volume 22, Issue 42 (29 September 2003)
Introduction
Biomolecular strategies for therapeutic intervention in cancer FREE
Antonio Giordano and Michele Maio
Oncogene 22: 6469; doi:10.1038/sj.onc.1207030
Guest Editors
Guest Editors FREE
Antonio Giordano and Michele Maio
Oncogene 22: 6470-6471; doi:10.1038/sj.onc.1206905
Reviews
Genetic and epigenetic alterations as hallmarks of the intricate road to cancer FREE
Marcella Macaluso, Marco G Paggi and Antonio Giordano
Oncogene 22: 6472-6478; doi:10.1038/sj.onc.1206955
Cancer epigenetics FREE
Richard L Momparler
Oncogene 22: 6479-6483; doi:10.1038/sj.onc.1206774
Epigenetic targets for immune intervention in human malignancies FREE
Michele Maio, Sandra Coral, Elisabetta Fratta, Maresa Altomonte and Luca Sigalotti
Oncogene 22: 6484-6488; doi:10.1038/sj.onc.1206956
Epigenetic targets in hematopoietic malignancies FREE
Rainer Claus and Michael Lübbert
Oncogene 22: 6489-6496; doi:10.1038/sj.onc.1206814
Advantages and limitations of microarray technology in human cancer FREE
Giuseppe Russo, Charles Zegar and Antonio Giordano
Oncogene 22: 6497-6507; doi:10.1038/sj.onc.1206865
Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability FREE
Patrizia Lavia, Anna Maria Mileo, Antonio Giordano and Marco G Paggi
Oncogene 22: 6508-6516; doi:10.1038/sj.onc.1206861
Viruses and cancer: lessons from the human polyomavirus, JCV FREE
Krzysztof Reiss and Kamel Khalili
Oncogene 22: 6517-6523; doi:10.1038/sj.onc.1206959
Axis of evil: molecular mechanisms of cancer metastasis FREE
Thomas Bogenrieder and Meenhard Herlyn
Oncogene 22: 6524-6536; doi:10.1038/sj.onc.1206757
Ocular neovascularization: a valuable model system FREE
Peter Anthony Campochiaro and Sean Francis Hackett
Oncogene 22: 6537-6548; doi:10.1038/sj.onc.1206773
Molecular basis of angiogenesis and cancer FREE
Tiziana Tonini, Francesca Rossi and Pier Paolo Claudio
Oncogene 22: 6549-6556; doi:10.1038/sj.onc.1206816
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels FREE
Ester Fonsatti, Maresa Altomonte, Maria Rita Nicotra, Pier Giorgio Natali and Michele Maio
Oncogene 22: 6557-6563; doi:10.1038/sj.onc.1206813
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach? FREE
Maresa Altomonte, Ester Fonsatti, Alberto Visintin and Michele Maio
Oncogene 22: 6564-6569; doi:10.1038/sj.onc.1206960
Biologic and therapeutic role of HER2 in cancer FREE
Sylvie Ménard, Serenella Marja Pupa, Manuela Campiglio and Elda Tagliabue
Oncogene 22: 6570-6578; doi:10.1038/sj.onc.1206779
The future of antisense therapy: combination with anticancer treatments FREE
Annamaria Biroccio, Carlo Leonetti and Gabriella Zupi
Oncogene 22: 6579-6588; doi:10.1038/sj.onc.1206812
Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor FREE
Eva Surmacz
Oncogene 22: 6589-6597; doi:10.1038/sj.onc.1206772
Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents FREE
Brian J Nickoloff, Barbara A Osborne and Lucio Miele
Oncogene 22: 6598-6608; doi:10.1038/sj.onc.1206758
Small-molecule cyclin-dependent kinase modulators FREE
Adrian M Senderowicz
Oncogene 22: 6609-6620; doi:10.1038/sj.onc.1206954
Pharmacogenomics: road to anticancer therapeutics nirvana? FREE
Apurva A Desai, Federico Innocenti and Mark J Ratain
Oncogene 22: 6621-6628; doi:10.1038/sj.onc.1206958
Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents FREE
Cesare Gridelli, Antonio Rossi and Paolo Maione
Oncogene 22: 6629-6638; doi:10.1038/sj.onc.1206957
Pathologic aspects of AIDS malignancies FREE
C Bellan, G De Falco, S Lazzi and L Leoncini
Oncogene 22: 6639-6645; doi:10.1038/sj.onc.1206815